Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
Severine Gharbi(Ludwig Cancer Research), Marı́a José Lallena(Eli Lilly (Spain)), M.T. Hilgers(Eli Lilly (United States)), Carmen Baquero(Eli Lilly (Spain)), Marjoke F. Debets(Eli Lilly (United States)), Howard B. Broughton(Eli Lilly (Spain)), Elisabet Zapatero(Eli Lilly (Spain)), Anna-Maria Russell(Eli Lilly (United States)), Alfonso Espada(Eli Lilly (Spain)), Alfonso de Dios(Eli Lilly (United States)), Leticia Cano(Eli Lilly (Spain)), Laura A. Pelletier(Eli Lilly (United States)), Nicholas Pulliam(Eli Lilly (United States)), Maria Patricia Ganado(Eli Lilly (Spain)), Sonia Maria Gutiérrez Sanfeliciano(Eli Lilly (Spain)), Raquel Torres(Eli Lilly (Spain)), Charles T. Rauch, Jesus A. Gutierrez(Eli Lilly (United States)), Sandra Gómez(Secretaría de Salud de Bogotá), Aiping Zhang(Yangzhou University), Óscar Puig(University of California, Berkeley), Jordi Benach(Eli Lilly (United States)), Carmen Maria Perez(Eli Lilly (Spain))
Cited by 29